Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma-Reference-Cited by-同舟云学术

Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma

Published:2006 Issue:10 Volume:107 Page:2436-2445
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kruper Laura L.,Spitz Francis R.,Czerniecki Brian J.,Fraker Douglas L.,Blackwood-Chirchir Anne,Ming Michael E.,Elder David E.,Elenitsas Rosalie,Guerry DuPont,Gimotty Phyllis A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

2. Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma

3. Sentinel-Node Biopsy or Nodal Observation in Melanoma

4. National Comprehensive Cancer Network: melanoma: clinical practice guidelines in oncology. v. 1. 2005. Available at http://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf

5. Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma;Expert Review of Molecular Diagnostics;2024-02-05

2. Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study;Journal of the American Academy of Dermatology;2023-12

3. Tumour regression predicts better response to interferon therapy in melanoma patients: a retrospective single centre study;Melanoma Research;2023-11-13

4. Evaluation of SLN status and its association with clinicopathological factors in patients with cutaneous melanoma: A retrospective study;MED BALEAR;2023

5. Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort;Annals of Surgical Oncology;2022-03-17